Brahmana Askandar (2020) HPV vaccine development after more than ten years approval. Majalah Obstetri dan Ginekologi, 28 (1). pp. 39-43. ISSN 0854-0381

	Text (Artikel) HPV Vaccine Development after more than ten years approval.pdf Download (250kB)
	Text (Peer Review) HPV vaccine development.pdf Download (2MB)
	Text (Similarity) HPV Vaccine Development after more than ten years approval.pdf Download (1MB)

Abstract

At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans. Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as in terms of the indications of the HPV vaccine use that is not only for preventing cervical cancer, the guidelines for administering 2-dose HPV vaccines for those under 15 years of age, and the discovery of the latest HPV vaccine types: nonavalent HPV vaccine. This review literature discusses all aspects of the development of HPV vaccine since it was first approved for use in humans in 2006.

Item Type:	Article
Uncontrolled Keywords:	HPV, effectiveness, immunogenicity, HPV nonavalent
Subjects:	R Medicine > R Medicine (General) R Medicine > RG Gynecology and obstetrics
Divisions:	01. Fakultas Kedokteran > Ilmu Kebidanan dan Kandungan
Creators:	Creators NIM Brahmana Askandar NIDN0014057304
Depositing User:	arys fk
Date Deposited:	14 Sep 2020 01:59
Last Modified:	14 Sep 2020 01:59
URI:	http://repository.unair.ac.id/id/eprint/98795
Sosial Share:

Actions (login required)

View Item